RELSYMPLA

What this means for you

Not registered yet, but its 03 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99862049

Mark type

Stylized text

Filed

03 Jun 2026

Attorney of record

Julia Anne Matheson

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of physical ailments; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of for skin wounds; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of for the treatment of burns; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of cardiovascular disease and cerebrovascular disease; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of neurological disease; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of cancer; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of osteoporosis; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of infectious diseases; pharmaceutical, peptide, and biologic preparations for the treatment of rheumatism; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of fever blisters; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of autoimmune diseases; pharmaceutical, peptide, and biologic preparations for the treatment of inflammation immunology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of organ transplant; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of pain; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of rare diseases; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of digestive diseases; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of hematologic disorders; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of kidney diseases; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of disease with immunosuppression; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in urology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in rheumatology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in nephrology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in organ transplant; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in hematology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in orthopedic medicine; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in pulmonology; drug delivery agents in the form of solutions, compounds, powders, and tablets that facilitate delivery of a wide range of pharmaceuticals, peptides, and biologics

Owner

• Veloxis Pharmaceuticals, Inc., Cary, NC, US

Prosecution history

• 03 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 03 Jun 2026 — APPLICATION FILING RECEIPT MAILED
• 03 Jun 2026 — NEW APPLICATION ENTERED